However, insulin sensitizers do not reverse fibrosis although it is associated with improved grade of steatosis, suggesting that insulin resistance might be necessary but not sufficient in the development of NAFLD [39]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.